Break on Through: Betty Eisner's Problematic Use of Psychedelics, Groups, and Control for Integrative Experiences.
Tal Davidson, Patric Plesa
Journal of the History of the Behavioral Sciences April 1, 2025 DOI: 10.1002/jhbs.70027 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Historical analysis Peer reviewed |
|---|---|
| Keywords | Group therapy Psychedelics Psychedelic‐assisted psychotherapy Hallucinogenic therapy Psychedelic treatment Betty eisner eisner Group counseling Social matrix therapy Medical ethics |
| Citations | 2 |
| Key points | Argues that the problematic practices of figures like Betty Eisner during the first wave of psychedelics research contributed to the decline of that era and the more cautious, conservative approach of the second wave, including slower development of group therapy and emphasis on social context. |
Abstract
Betty Eisner represents a prominent figure in the "golden age" of psychedelics research, as well as a cautionary tale about questionable therapeutic practices, exercising authority and control, and the misuse of psychedelics during the counterculture of the 1960s and 70s. Situating her work and the consequences of her problematic practices in the counterculture, the Human Potential Movement, and integrative experiences helps provide some context for the decline of the first wave of psychedelics research and the more cautious and conservative approach to the second wave of psychedelics research. Some of the dangers associated with figures like Eisner, and consequently the first wave of psychedelics, may help explain the slower development of group therapy approaches and the inclusion of social context in the second wave focus on psychedelic-assisted psychotherapy.
Citations in the library
Cites 18
- Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology July 1, 2008
- The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future. Neuropsychopharmacology April 26, 2017
- Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study EClinicalMedicine September 24, 2020
- The Therapeutic Potential of Psilocybin Molecules May 15, 2021
- Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews Expert Review of Clinical Pharmacology August 13, 2018
and 13 more in the library